LifeMD Inc
$ 4.70
-4.08%
12 Jun - close price
- Market Cap 227,304,000 USD
- Current Price $ 4.70
- High / Low $ 4.90 / 4.61
- Stock P/E N/A
- Book Value 0.32
- EPS -0.44
- Next Earning Report 2026-08-04
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.13 %
- ROE -2.38 %
- 52 Week High 15.84
- 52 Week Low 2.56
About
LifeMD, Inc. is a direct-to-patient telehealth company connecting consumers with healthcare professionals for care in various indications, including concierge care, men's sexual health, dermatology, and others in the United States. . The company is headquartered in New York, New York.
Analyst Target Price
$9.88
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-06 | 2026-03-09 | 2025-11-17 | 2025-08-04 | 2025-05-06 | 2025-03-10 | 2024-11-07 | 2024-08-07 | 2024-05-08 | 2024-03-11 | 2023-11-08 | 2023-08-09 |
| Reported EPS | -0.1516 | 0.0568 | -0.1 | -0.06 | 0.0282 | 0.21 | -0.14 | -0.19 | -0.19 | -0.12 | -0.2 | -0.23 |
| Estimated EPS | -0.1167 | -0.065 | -0.04 | -0.02 | 0.14 | 0.14 | -0.12 | -0.12 | -0.15 | -0.14 | -0.15 | -0.1 |
| Surprise | -0.0349 | 0.1218 | -0.06 | -0.04 | -0.1118 | 0.07 | -0.02 | -0.07 | -0.04 | 0.02 | -0.05 | -0.13 |
| Surprise Percentage | -29.9057% | 187.3846% | -150% | -200% | -79.8571% | 50% | -16.6667% | -58.3333% | -26.6667% | 14.2857% | -33.3333% | -130% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-04 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | -0.2 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: LFMD
2026-06-11 18:39:45
LifeMD, Inc. (LFMD) reported a narrower-than-expected loss for the first quarter, with an adjusted loss of $0.06 per share. The company also exceeded revenue estimates, generating $37.56 million compared to the anticipated $37.16 million. Despite the revenue beat, the company's net loss widened significantly from the previous year.
2026-06-10 15:20:00
This article provides an in-depth analysis of Lifemd Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ: LFMDP), highlighting a neutral sentiment across all time horizons. It presents three distinct AI-generated trading strategies—position trading, momentum breakout, and risk hedging—along with key support and resistance levels. The analysis points to an exceptional 13.1:1 risk-reward short setup, signaling potential for a 3.8% downside.
2026-06-04 01:40:17
LifeMD, Inc.'s Chief Technology Officer, Sripad Umesh, received a grant of 75,000 shares of common stock as compensation, indicating a neutral impact and sentiment. These shares are restricted stock units that will vest in three installments over three years: 25,000 units on June 1, 2027, another 25,000 on June 1, 2028, and the remainder on June 1, 2029. This award increases Umesh's direct holdings to 75,000 shares, serving as a multi-year equity incentive according to the Form 4 filing.
2026-06-04 01:40:17
LifeMD, Inc.'s Chief Technology Officer, Sripad Umesh, has submitted his initial Form 3 filing, an SEC document reporting beneficial ownership of securities. The filing identifies Umesh as an officer but not a ten percent owner of the company, and it states that there were no share transactions or derivative holdings at the time of the report. This Form 3 serves as an initial baseline for his ownership status as an insider at LifeMD (LFMD).
2026-06-02 03:39:39
LifeMD has announced the appointment of Umesh Sripad as its new Chief Technology Officer. Sripad brings extensive experience from his previous executive roles at companies like Best Buy and Amazon, where he led significant technological advancements and strategic initiatives. His expertise is expected to drive innovation and enhance the operational efficiencies of LifeMD's virtual primary care and weight management platforms.
2026-06-02 02:40:17
LifeMD, Inc. has appointed Umesh Sripad as its new Chief Technology Officer, effective immediately. Mr. Sripad brings over two decades of experience in digital transformation and will be responsible for leading LifeMD's technology strategy, AI enablement, cybersecurity, and scalability initiatives. This appointment comes as LifeMD accelerates its growth from a virtual pharmacy platform to a comprehensive primary and specialty care provider aiming to serve millions of patients.
